Search

everythinglearnresearchcommunity

for

Search:↓

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Topical finasteride may be safer than oral finasteride, but more research is needed.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Restoring hair follicle communication may treat hair loss and improve sexual dysfunction.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Finasteride caused serious side effects and led to six suicides.

Dutasteride and finasteride don't raise erectile dysfunction risk.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Finasteride can cause lasting erectile dysfunction, low libido, and depression in some patients.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Antidepressants can cause long-term side effects like severe withdrawal symptoms and sexual dysfunction, which can last for months or years after stopping the medication.

Finasteride increases hair count in middle-aged and elderly men without causing sexual dysfunction.

Restoring communication in hair follicle networks may treat hair loss and improve sexual dysfunction.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Finasteride can cause lasting sexual and mood issues even after stopping the drug.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

Finasteride may cause lasting sexual issues by altering specific genes in human cells.